- GLP-1 agonists in type 1 diabetesJeremy Pettus
University of California San Diego, San Diego, CA, USA Veterans Affairs Hospital, La Jolla, CA, USA Electronic address
Clin Immunol 149:317-23. 2013..The purpose of this article is to review the preclinical and clinical data of these agents to date with a focus on the potential immunological and clinical benefits these drugs may have on patients with type 1 diabetes. ..